A guinea pig heart Langendorif preparation was used in the present study to test the hypothesis that the coronary endothelium modulates coronary autoregulation through the production of nitric oxide (NO is an oversupply of oxygen, and diffusible metabolites are even more easily washed out of the heart. It is now clear that vascular endothelium modulates flow autoregulation. Mechanical denudation of the endothelium or endothelial injury by agents such as the combination of Evans blue plus irradiation by a heliumneon laser can enhance the myogenic response of isolated coronary8 and cerebral9 arteries. Endotheliumdependent relaxation factors, particularly nitric oxide (NO),10-12 participate in the setting of basal tone in many vascular beds, including the coronary circulation.'3-16 Competitively inhibiting the formation of NO from L-arginine, its natural precursor, 17, 8 by means of analogues of L-arginine19 is an important tool for assessing the contribution of NO in vasodilator responses. Thus, Griffith and Edwards20 have shown that an isolated, buffer-perfused rabbit ear preparation that lacks the ability to autoregulate will develop the capacity to autoregulate under the combined influences of vasoconstriction by serotonin and the inhibition of NO production by NG-methyl-L-arginine.
C oronary autoregulation is the intrinsic ability of the heart to maintain its nutritive blood supply relatively constant over a rather wide range of perfusion pressure.'2 Autoregulation appears to reflect the interaction of myogenic tone, the tendency of vascular smooth muscle to contract in response to a rise in the transmural pressure differential,3 with the opposing effect(s) of one or more endogenous vasodilators. Metabolites released from the heart could play a role in autoregulation. Changing myocardial oxygen consumption (MVo2) causes a concordant, nearly parallel shift of the pressure-flow curve along the flow axis.45 One such metabolite, adenosine, appears to play no role in setting coronary tone within the autoregulatory range67 but could be important below that range, where flow and, therefore, oxygen delivery fall as a function of falling perfusion pressure. Metabolites whose production is linked to cardiac metabolism cannot explain the loss of the capacity to autoregulate at pressures above the autoregulatory range. Under such circumstances, there is an oversupply of oxygen, and diffusible metabolites are even more easily washed out of the heart. It is now clear that vascular endothelium modulates flow autoregulation. Mechanical denudation of the endothelium or endothelial injury by agents such as the combination of Evans blue plus irradiation by a heliumneon laser can enhance the myogenic response of isolated coronary8 and cerebral9 arteries. Endotheliumdependent relaxation factors, particularly nitric oxide (NO),10-12 participate in the setting of basal tone in many vascular beds, including the coronary circulation. '3-16 Competitively inhibiting the formation of NO from L-arginine, its natural precursor, 17, 8 by means of analogues of L-arginine19 is an important tool for assessing the contribution of NO in vasodilator responses. Thus, Griffith and Edwards20 have shown that an isolated, buffer-perfused rabbit ear preparation that lacks the ability to autoregulate will develop the capacity to autoregulate under the combined influences of vasoconstriction by serotonin and the inhibition of NO production by NG-methyl-L-arginine.
Our present article describes studies of isolated guinea pig hearts that test the hypothesis that NO modulates coronary autoregulation.
Materials and Methods We used 28 Langendorff preparations from guinea pigs weighing 300-400 g. The perfusate consisted of (mM) NaCI 120, NaHCO3 27, KCI 3.7, MgSO4 0.64, to 37°C, and delivered initially at a pressure equivalent to 55 mm Hg. Right ventricular pacing at 250 beats per minute and draining the left ventricular cavity by means of a catheter inserted across the mitral valve were attempted to keep the metabolic component of coronary tone constant. The superior and inferior venae cavae were ligated, and the pulmonary artery was cannulated to obtain quantitative collections of coronary effluent. An electromagnetic flow probe in the aortic perfusion line monitored coronary flow rate, which was also measured by timed collections of pulmonary artery effluent. Samples of aortic perfusate and pulmonary artery effluent collected anaerobically were assayed for P02, Pco2, and pH. Statistical analysis was used for the determination of correlations that might point to the mechanism(s) underlying autoregulation. In the experimental design, the autoregulation index was considered the dependent variable; the independent variables included, with possible mechanisms of action in parentheses, 1) perfusion pressure (stimulus to myogemnc contraction), 2) coronary flow (shear stress on endothelial cells), 3) Oxygen Extrcaction (%) 15 25 Figure 5 shows the effect of arginine vasopressin, a direct smooth muscle constrictor, on autoregulation. At a concentration of 1 nM, vasopressin lowered coronary flow by 40% at a coronary perfusion pressure of 55 mm Hg, a degree of constriction similar to that produced by NNLA. However, unlike NNLA, vasopressin did not prevent active coronary vasodilation at perfusion pressures of 65 mm Hg and higher, resulting in a minor change in the width of the autoregulation range. The combination of NNLA and vasopressin depressed active vasodilation at pressures higher than 55 mm Hg, thereby widening the autoregulation range.
Effect of Vasopressin on Autoregulation
Vasopressin produced changes in MVo2 and the chemical composition of the coronary venous effluent that were qualitatively similar to those produced by NNLA (data not shown, but refer to Figure 4 ). Vasopressin significantly lowered MVo2 at all levels of per- 
Statistical Analysis
Under control conditions, there was a biphasic relation between the autoregulation index and, respectively, perfusion pressure, coronary flow, and coronary effluent Po2 (Figure 2 effect on coronary flow or coronary effluent Po2, and the autoregulation index changed very little. The correlation coefficient relating autoregulation index and perfusion pressure was lower by half than under control conditions, and the correlations between the autoregulation index and the other independent variables were weaker still (Table 1) .
Discussion The important findings that emerge from this study are as follows: 1) The inhibition of NO synthase by NNLA greatly enhances the ability of the coronary circulation to autoregulate in response to changes in perfusion pressure. 2) L-Arginine stereospecifically reverses this effect. 3) Coronary smooth muscle constriction by means of arginine vasopressin does not prevent the loss of autoregulatory capacity that occurs at elevated perfusion pressures. 4) Inhibition of the cyclooxygenase pathway by indomethacin has no effect on autoregulation. The actions of NNLA and L-arginine imply that NO modulates autoregulation in the coronary bed. The failure of vasopressin to prevent escape from autoregulation at the upper end of the pressure range is evidence that NNLA acts primarily by suppressing the production of a vasodilator rather than by actively promoting vasoconstriction.
The present investigation used an experimental preparation similar to those used by others to study coronary autoregulation,22'23 and the preparation exhibited autoregulation over a similar range of perfusion pressures. Advantages of this preparation, which does no external work, are as follows: 1) Oxygen demand is lower than that of a heart performing external work, which increases the ability of the hearts to tolerate perfusion at low pressures, where oxygen delivery may be compromised.
2) The combination of pacing and a low work load lessens the likelihood that significant variations in MVo2 will cause metabolic coronary vasodilation that would obscure autoregulation. However, the pressure ranges of autoregulation in the present and earlier studies of guinea pigs are substantially lower than the ranges typically exhibited in studies of blood-perfused dog hearts. 4, 5, 7, 24 The reason for this systematic difference is uncertain, but possible explanations include the difference in species, degree of extravascular coronary compression, and viscosity of the coronary perfusate.
Dole and Nuno24 have observed that a coronary venous Po2 that is low but within the physiological range facilitates the capacity for coronary autoregulation. 24 Their statistical analysis identified a strong correlation between coronary venous Po2 and the autoregulation index. They propose that lowering perfusion pressure lowers myocardial P02, which either relaxes the coronary resistance vessels directly or, alternatively, causes the release of vasodilatory metabolites. In that model, vasodilator production is an inverse function of perfusion pressure. Our observations suggest an alternative model that consists of a combination of myogenic vasoconstriction opposed by the production of vasodilator(s) as a direct rather than inverse function of perfusion pressure. The use of NNLA, a reagent not available to Dole and Nuno, identified NO as one of the vasodilators produced in proportion to perfusion pressureflow, but the experimental design does not exclude the participation of others. The statistical analysis of the hemodynamic and perfusate composition measurements ( Figure 3 and Table 1 ) does not support a major role for either myocardial Pco2 or pH in coronary autoregulation in the isolated, buffer-perfused guinea pig heart.
Known stimuli to the production of NO by endothelial cells include a number of agonists that act through receptors on the endothelial cell surface25 and shear stress exerted on the endothelium by blood flowing over it.26-29 Stretch, usually thought of as a stimulus to blood vessel contraction,30-34 may also stimulate the release of NO. 35 In the present experiments, shear stress and, possibly, stretch seem the most likely stimuli to NO production.
An alternative explanation for the ability of NNLA to enhance the capacity of the coronary circulation to autoregulate is that basal NO production is artificially high in the isolated heart preparations we used. According to that line of reasoning, vasodilators modulate the capacity to autoregulate, and so the administration of NNLA improves autoregulation by inhibiting the production of one such vasodilator, NO. However, it is not certain that NO production was abnormal in our preparations. The vasoconstrictor effect of NNLA that we observed resembles that seen in a far more physiological preparation, namely, the conscious dog instrumented for measurements of coronary artery diameter.14'36 ' 
